P5.082 What Are the Costs and Benefits of Implementing Point of Care Tests For Chlamydia Trachomatis...
P5.082 What Are the Costs and Benefits of Implementing Point of Care Tests For Chlamydia Trachomatis and Neisseria Gonorrhoeae in Genitourinary Medicine Clinics?
About this item
Full title
Author / Creator
Turner, K M , Round, J , Deol, A , Horner, P , Macleod, J , Goldenberg, S and Adams, E
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Background To estimate the costs and benefits of new patient pathways in genitourinary medicine (GUM) clinics that incorporate a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea (CT/NG), compared to standard off-site laboratory testing. Method We modelled 20,000 GUM clinic attendees, based on GUMCAD reported d...
Alternative Titles
Full title
P5.082 What Are the Costs and Benefits of Implementing Point of Care Tests For Chlamydia Trachomatis and Neisseria Gonorrhoeae in Genitourinary Medicine Clinics?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1781717415
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1781717415
Other Identifiers
ISSN
1368-4973
E-ISSN
1472-3263
DOI
10.1136/sextrans-2013-051184.1126
